REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 132 filers reported holding REVANCE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,928,211 | +9.7% | 342,477 | +142.0% | 1.22% | +33.5% |
| Q2 2023 | $3,581,365 | +151.7% | 141,500 | +61.3% | 0.91% | +168.7% |
| Q4 2019 | $1,423,000 | -64.2% | 87,700 | -71.3% | 0.34% | -73.5% |
| Q3 2019 | $3,974,000 | -24.1% | 305,664 | -24.3% | 1.28% | +1.4% |
| Q2 2019 | $5,236,000 | +30.5% | 403,664 | +58.6% | 1.26% | +16.5% |
| Q1 2019 | $4,012,000 | +18.8% | 254,581 | +51.8% | 1.08% | -12.0% |
| Q4 2018 | $3,376,000 | -17.3% | 167,724 | +2.1% | 1.23% | -12.2% |
| Q3 2018 | $4,084,000 | +46.9% | 164,353 | +62.3% | 1.40% | -8.8% |
| Q2 2018 | $2,780,000 | – | 101,292 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
| Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
| Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
| Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
| Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
| Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
| Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
| TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |